Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
01 04 2020
Historique:
received: 07 06 2019
accepted: 27 10 2019
pubmed: 20 11 2019
medline: 29 6 2021
entrez: 20 11 2019
Statut: ppublish

Résumé

Limited evidence is available on the temporal relationship between atrial fibrillation (AF) and ischaemic stroke and their impact on mortality in the community. We sought to understand the temporal relationship of AF and ischaemic stroke and to determine the sequence of disease onset in relation to mortality. Across five prospective community cohorts of the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) project we assessed baseline cardiovascular risk factors in 100 132 individuals, median age 46.1 (25th-75th percentile 35.8-57.5) years, 48.4% men. We followed them for incident ischaemic stroke and AF and determined the relation of subsequent disease diagnosis with overall mortality. Over a median follow-up of 16.1 years, N = 4555 individuals were diagnosed solely with AF, N = 2269 had an ischaemic stroke but no AF diagnosed, and N = 898 developed both, ischaemic stroke and AF. Temporal relationships showed a clustering of diagnosis of both diseases within the years around the diagnosis of the other disease. In multivariable-adjusted Cox regression analyses with time-dependent covariates subsequent diagnosis of AF after ischaemic stroke was associated with increased mortality [hazard ratio (HR) 4.05, 95% confidence interval (CI) 2.17-7.54; P < 0.001] which was also apparent when ischaemic stroke followed after the diagnosis of AF (HR 3.08, 95% CI 1.90-5.00; P < 0.001). The temporal relations of ischaemic stroke and AF appear to be bidirectional. Ischaemic stroke may precede detection of AF by years. The subsequent diagnosis of both diseases significantly increases mortality risk. Future research needs to investigate the common underlying systemic disease processes.

Identifiants

pubmed: 31740944
pii: 5628282
doi: 10.1093/europace/euz312
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

522-529

Commentaires et corrections

Type : CommentIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

Stephan Camen (S)

Department of General and Interventional Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Hamburg, Germany.

Francisco M Ojeda (FM)

Department of General and Interventional Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.

Teemu Niiranen (T)

Finnish Institute for Health and Welfare, Helsinki, Finland.
Department of Medicine, Turku University Hospital and University of Turku, Finland.

Francesco Gianfagna (F)

Research Center in Epidemiology and Preventive Medicine (EPIMED), Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Mediterranea Cardiocentro, Napoli, Italy.

Julie K Vishram-Nielsen (JK)

Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark, Copenhagen, Denmark.
Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Simona Costanzo (S)

Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Isernia, Italy.

Stefan Söderberg (S)

Department of Public Health and Clinical Medicine, and Heart Centre, Umeå University, Umeå, Sweden.

Erkki Vartiainen (E)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Maria Benedetta Donati (MB)

Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Isernia, Italy.

Maja-Lisa Løchen (ML)

Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.

Gerard Pasterkamp (G)

Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht, The Netherlands.

Christina Magnussen (C)

Department of General and Interventional Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Hamburg, Germany.

Frank Kee (F)

Centre for Public Health, Queens University Belfast, Belfast, UK.

Pekka Jousilahti (P)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Maria Hughes (M)

Centre for Public Health, Queens University Belfast, Belfast, UK.

Jukka Kontto (J)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Ellisiv B Mathiesen (EB)

Brain and Circulation Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.

Wolfgang Koenig (W)

German Heart Center Munich, Technical University of Munich, Munich, Germany.
German Centre for Cardiovascular Research (DZHK e.V.), partner site Munich Heart Alliance, Munich, Germany.
Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.

Tarja Palosaari (T)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Stefan Blankenberg (S)

Department of General and Interventional Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Hamburg, Germany.

Giovanni de Gaetano (G)

Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Isernia, Italy.

Torben Jørgensen (T)

Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark, Copenhagen, Denmark.
Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Faculty of Medicine, Aalborg University, Aalborg, Denmark.

Tanja Zeller (T)

Department of General and Interventional Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Hamburg, Germany.

Kari Kuulasmaa (K)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Allan Linneberg (A)

Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark, Copenhagen, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Veikko Salomaa (V)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Licia Iacoviello (L)

Research Center in Epidemiology and Preventive Medicine (EPIMED), Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Isernia, Italy.

Renate B Schnabel (RB)

Department of General and Interventional Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH